Days
Hours
Minutes
Seconds

Improving lives with constant updates & research and promising a better & healthier future!

Register Now

W

Welcome Message

It is my pleasure to welcome you to the 1st Middle East Cardiovascular Pharmacotherapy Forum to be held on 14th October 2023 at Jumeirah Creekside hotel, Dubai.

In this emerging era of increased heart disease, particularly in the Middle East region, we take this opportunity to discuss the latest advancement in cardiovascular pharmacotherapy and to have our forum as a “Call for Action” for implementing guideline directed medical therapy in our region.

This inaugural version of the forum will aim to bring together prominent individuals in the field ‎both in the region and internationally and will be inclusive of all cardiovascular ‎pharmacotherapy practice settings. ‎

We look forward to welcoming you in Dubai. With your important contribution we aim to have ‎MECVPT forum as the primary scientific gathering of cardiovascular pharmacotherapy ‎specialists in the region and to become an awaited yearly event.

Dr. Bassam Atallah

 Pharm.D., M.S., BCPS-AQ Cardiology, FHFSA
Chairman, MECVPT 2023
Clinical Associate Professor
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Heart and Vascular Institute Pharmacotherapy Specialist
Cleveland Clinic Abu Dhabi
United Arab Emirates

O

Our Faculty

*Faculty is arranged Alphabetically

Ahmad El Ouweini
Critical Care Clinical Pharmacist and Clinical Lecturer
Gulf Medical University
United Arab Emirates
Ahmed Aljedai
Founding President
Saudi Society of Clinical Pharmacy (SSCP)
Assistant Deputy Minister for Therapeutic Affairs
Ministry of Health, Riyadh
Saudi Arabia

Ahmed Aldemerdash​
Chairman, Pharmacy Scientific Council Saudi Commission for Health Specialties (SCFHS) ​
Saudi Arabia​

Amnah Mukhtar
Head Medication
Safety/Clinical Pharmacy Support Services
King Faisal Specialist Hospital and Research Center, Jeddah
Saudi Arabia
Antoine Cherfan
Senior Director
Pharmacotherapy Services
Cleveland Clinic Abu Dhabi
United Arab Emirates
Bassam Atallah​
Senior Pharmacotherapy Specialist​ Department of Pharmacy Services ​ Cleveland Clinic Abu Dhabi
United Arab Emirates
Bassam R. Ali​
Professor of Genomic Medicine
College of Medicine and Health Sciences
United Arab Emirates University
United Arab Emirates
Craig James Beavers​​
Vice President, Operations Executive/Clinical Leader for Cardiovascular, Surgical Services, Pharmacy, Oncology/Radiology, Facilities, Environmental Services, Business Development, Food and Nutrition Services Baptist Health Paducah
United States​
Emad El Kholy​​
Cardiology/Critical care
Pharmacist​
King Abdullah Medical City​
Saudi Arabia​​
Emadeldin Hosney Eldaly​​
Clinical Pharmacist / Cardiology and internal medicine​
Sheikh Khalifa medical city (SKMC)​
United Arab Emirates
Fakhr Z. AlAyoubi
President, Saudi Cardio Clinical Pharmacy Group at the Saudi Heart Association
Saudi Heart Society
Saudi Arabia
Hisham Badreldin Associate Professor
Consultant Cardiovascular Pharmacotherapy Specialist
Department of Pharmacy
Practice, College of Pharmacy
King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS)
King Abdullah International Medical Research Center (KAIMRC)
King Abdulaziz Medical City (KAMC)
Ministry of National Guard Health Affairs (MNGHA) Riyadh
Saudi Arabia
Jamila Alaryani​​​
PGY1 Pharmacy Resident
Cleveland Clinic Abu Dhabi
United Arab Emirates
Kazuhiko Kido​​​
Clinical Associate Professor​ Clinical Pharmacy West Virginia University (WVU) School of Pharmacy​
United States​
Mohamad Shara​​​
Visiting Associate Professor of Clinical Pharmacy
University of Sharjah, College of pharmacy
United Arab Emirates
Nibal Chamoun​​​ Clinical Associate Professor and Assistant Dean of Experiential Education and Residency Program
Lebanese American University (LAU) School of Pharmacy (SOP)
Lebanon
Rahmeh Qandil​​​
Clinical Tutor
University of Sharjah, College of Pharmacy
United Arab Emirates
Salahdein Mohammed AbuRuz​​​
Director of PharmD and PhD programs, Professor of Clinical Pharmacy and Pharmacotherapy/ Department of Pharmacology and Therapeutics, United Arab Emirate University
United Arab Emirates​
Saad Sultan
Executive Director of Pharmacy Services
Cleveland Clinic Abu Dhabi
United Arab Emirates
Said Nabil​
International Relations Committee
Heart Failure Society of America (HFSA)
Researcher Cleveland Clinic Abu Dhabi
United Arab Emirates
Salma Alzaabi​​​
Clinical staff Pharmacist
Cleveland Clinic Abu Dhabi
United Arab Emirates
Sana Hasan​​​​
Associate Professor of Clinical Pharmacy & Coordinator of the MSc in Clinical Pharmacy Program
Ajman University College of Pharmacy and Health Sciences
United Arab Emirates
Seeba Zachariah​​​​
Clinical Assistant Professor, Department of Pharmacy Practice, College of Pharmacy, Gulf Medical University
United Arab Emirates​
Ziad Sadik​
Senior Pharmacotherapy Specialist: Cardiology and Internal Medicine Cleveland Clinic Abu Dhabi​
United Arab Emirates

A

Agenda

Session 1
Chairperson : ABC

  • 10:15 - 10:45 AM

Dr. Mohamed Salah

Topic 1

  • 10:45 - 11:15 AM

Dr. Mohamed Salah

Topic 2

  • 11:15 - 11:45 AM

Dr. Mohamed Salah

Topic 3

  • 11:45 - 12:00 PM

Topic 4

  • 12:00 - 12:15 PM

Discussion

  • 12:15 - 02:15 PM

Prayer & Lunch

Session 2
Chairperson : Prof. ABC

  • 02:15 - 02:45 PM

Dr. Mohamed Salah

Topic 1

  • 02:45 - 03:15 PM

Dr. Mohamed Salah

Topic 2

  • 03:45 - 04:00 PM

Discussion

  • 04:00 - 04:15 PM

Coffee Break

Session 3
Chairperson : Dr. ABC

  • 04:15 - 04:45 PM

Dr. Mohamed Salah

Topic 1

  • 04:45 - 05:15 PM

Dr. Mohamed Salah

Topic 2

  • 05:15 - 05:45 PM

Dr. Mohamed Salah

Topic 3

  • 05:45 - 06:00 PM

Discussion

Coming Soon

Click on the session name for more details about the session

Saturday, October 14, 2023

TimePlenary HallBreakout Room
09:00 AM - 09:15 AM Welcome, introductions to the agenda and key objectives of the conference

Welcome, introductions to the agenda and key objectives of the conference

Saturday, October 14, 2023 at 09:00 AM - 09:15 AM on

Topics :

Welcome, introductions to the agenda and key objectives of the conference.
Bassam Atallah
Cleveland Clinic Abu Dhabi
12:00 AM - 12:00 AM

Close

x

Thursday, January 01, 1970 at 12:00 AM - 12:00 AM on

Close

x
09:15 AM - 09:35 AM Keynote I Breaking the Silos: How to Design an Effective Pharmacy Practice Model

Keynote I

Chairperson :

Bassam Atallah
Cleveland Clinic Abu Dhabi

Topics :

Breaking the Silos: How to Design an Effective Pharmacy Practice Model
Saad Sultan
United Arab Emirates
09:15 AM - 09:35 AM

Close

x
09:35 AM - 09:55 AM Keynote II Designing a Specialty Clinical Service: Challenges and Opportunities

Keynote II

Chairperson :

Salma Alzaabi
United Arab Emirates

Topics :

Designing a Specialty Clinical Service: ‎Challenges and Opportunities
Ahmed Aljedai
Saudi Arabia
09:35 AM - 09:55 AM

Close

x
09:55 AM - 10:10 AM Pharmacotherapy Services at Cleveland Clinic Abu Dhabi

Pharmacotherapy Services at Cleveland Clinic Abu Dhabi

Chairperson :

Seeba Zachariah
United Arab Emirates

Topics :

Pharmacotherapy Services at Cleveland Clinic Abu Dhabi
Antoine Cherfan
United Arab Emirates
09:55 AM - 10:10 AM

Close

x
10:10 AM - 10:40 AM Cardiovascular Disease Guideline Directed Medical Therapy in the Middle East: A Call for Action

Cardiovascular Disease Guideline Directed Medical Therapy in the Middle East: A Call for Action

Chairperson :

Amnah Mukhtar
Saudi Arabia

Topics :

Cardiovascular Disease Guideline Directed Medical Therapy in the Middle East: A Call for Action
Hisham Badreldin
Saudi Arabia
10:10 AM - 10:25 AM
Cardiovascular Disease Guideline Directed Medical Therapy in the Middle East: A Call for Action
Bassam Atallah
Cleveland Clinic Abu Dhabi
10:25 AM - 10:40 AM

Close

x
10:40 AM - 11:00 AM Coffee Break I
11:00 AM - 11:15 AM Session I - Designing a Cardiology Clinical Rotation

Session I - Designing a Cardiology Clinical Rotation

Chairperson :

Ziad Sadik
United Arab Emirates

Topics :

Designing a Cardiology Clinical Rotation
Ahmed Aldemerdash
Saudi Arabia
11:00 AM - 11:15 AM

Close

x
11:15 AM - 12:00 PM Session II - Conducting Research in Cardiovascular Pharmacotherapy

Session II - Conducting Research in Cardiovascular Pharmacotherapy

Chairperson :

Sanah Hasan
United Arab Emirates

Topics :

Evaluation of the impact of Point-of-Care Platelet Reactivity and Pharmacogenetic Testing and a comprehensive approach to manage antiplatelet resistance on the outcomes of patients with cardiovascular diseases: A quasi-experimental design
Salah AbuRuz
United Arab Emirates
11:15 AM - 11:30 AM
Implementation of Pharmacogenomics: The Case for Cardiovascular Diseases in the United Arab Emirates
Bassam Ali
United Arab Emirates
11:30 AM - 11:45 AM
Clinical Research in Cardiovascular Pharmacotherapy
Moh'd Ahmad Shara
United Arab Emirates
11:45 AM - 12:00 PM

Close

x
12:00 PM - 01:00 PM Lunch Break
01:00 PM - 01:45 PM Session III - Acute Coronary Syndrome and Postoperative Cardiac Surgery

Session III - Acute Coronary Syndrome and Postoperative Cardiac Surgery

Chairperson :

Rahmeh Qandil
United Arab Emirates

Topics :

A Review of the Management of Acute Coronary Syndromes
Nibal Chamoun
Lebanon
01:00 PM - 01:15 PM
A Review of the Management of Postoperative Cardiac Surgery Patients
Bassam Atallah
Cleveland Clinic Abu Dhabi
01:15 PM - 01:30 PM
Debate: Colchicine or no colchicine for all post cardiac surgery patients?
Seeba Zachariah
United Arab Emirates
01:30 PM - 01:38 PM
Debate: Colchicine or no colchicine for all post cardiac surgery patients?
Nibal Chamoun
Lebanon
01:38 PM - 01:45 PM

Close

x
01:45 PM - 02:15 PM Session IV - Anticoagulation Pharmacotherapy

Session IV - Anticoagulation Pharmacotherapy

Chairperson :

Ziad Sadik
United Arab Emirates

Topics :

When do we really still need to use warfarin?
Bassam Atallah
Cleveland Clinic Abu Dhabi
01:45 PM - 02:00 PM
Debate: DOAC use for LV thrombus and Cancer Associated Thrombosis
Elkholy Emad
United Arab Emirates
02:00 PM - 02:08 PM
Debate: DOAC use for LV thrombus and Cancer Associated Thrombosis
Hisham Badreldin
Saudi Arabia
02:08 PM - 02:15 PM

Close

x
02:15 PM - 03:00 PM Session V- Updates on Lipids Management

Session V- Updates on Lipids Management

Chairperson :

Ahmed Aldemerdash
Saudi Arabia

Topics :

Review of the 2022 ACC/AHA nonstatin lipid statement
Salma Alzaabi
United Arab Emirates
02:15 PM - 02:30 PM
Where are we with the injectable cholesterol medications?
Fakhr Alayoubi
Saudi Arabia
02:30 PM - 02:45 PM

Close

x
03:00 PM - 03:15 PM Coffee Break - II
03:15 PM - 03:45 PM Session VI - Management of Pulmonary Hypertension

Session VI - Management of Pulmonary Hypertension

Chairperson :

Emadeldin Hosny El Daly
United Arab Emirates

Topics :

Debate: Initial Triple Combination Therapy vs. Sequential Therapy in PAH Patients
Ziad Sadik
United Arab Emirates
03:15 PM - 03:23 PM
Debate: Initial Triple Combination Therapy vs. Sequential Therapy in PAH Patients
Ahmad El Ouweini
United Arab Emirates
03:23 PM - 03:30 PM
Debate: Optimal Anticoagulation for CTEPH Patients: VKA vs DOAC
Kazuhiko Kido
United States
03:30 PM - 03:38 PM
Debate: Optimal Anticoagulation for CTEPH Patients: VKA vs DOAC
Hisham Badreldin
Saudi Arabia
03:38 PM - 03:45 PM

Close

x
03:45 PM - 04:30 PM Session VII - Antiarrhythmic Pharmacotherapy

Session VII - Antiarrhythmic Pharmacotherapy

Chairperson :

Salah AbuRuz
United Arab Emirates

Topics :

Antiarrhythmic Pharmacotherapy: A Pharmacology Review
Amnah Mukhtar
Saudi Arabia
03:45 PM - 04:00 PM
Debate: CCB vs Adenosine for SVT
Kazuhiko Kido
United States
04:00 PM - 04:08 PM
Debate: CCB vs Adenosine for SVT
Ziad Sadik
United Arab Emirates
04:08 PM - 04:15 PM
Debate: Amiodarone vs Lidocaine for VT/VF
Seeba Zachariah
United Arab Emirates
04:15 PM - 04:23 PM
Debate: Amiodarone vs Lidocaine for VT/VF
Saeed Nabil
United Arab Emirates
04:23 PM - 04:30 PM

Close

x
04:30 PM - 04:50 PM Keynote III Cardiology Professional Organizations and Societies: What can Pharmacists do?

Keynote III

Topics :

Cardiology Professional Organizations and Societies: What can Pharmacists do?
Craig Beavers
United States
04:30 PM - 04:50 PM

Close

x
04:50 PM - 05:45 PM Session VIII - Updates on Heart Failure Management

Session VIII - Updates on Heart Failure Management

Chairperson :

Hisham Badreldin
Saudi Arabia

Topics :

Review of the 2022 ACC/AHA/HFSA Guidelines for the management of HF
Bassam Atallah
Cleveland Clinic Abu Dhabi
04:50 PM - 05:05 PM
Iron Replacement in Heart Failure: HFSA Statement and current practice
Craig Beavers
United States
05:05 PM - 05:20 PM
Pharmacist Led Protocol for Iron Replacement in Heart Failure
Jamila Alaryani
United Arab Emirates
05:20 PM - 05:30 PM
Defining the role of “additional therapies” in Heart Failure: Vericiguat place in therapy and more
Ziad Sadik
United Arab Emirates
05:30 PM - 05:45 PM

Close

x
05:45 PM - 06:00 PM Session IX - Endocarditis

Session IX - Endocarditis

Chairperson :

Jamila Alaryani
United Arab Emirates

Topics :

Endocarditis: Behind the Guideline Lines
Elkholy Emad
United Arab Emirates
05:45 PM - 06:00 PM

Close

x
06:00 PM - 06:15 PM Discussion, Meeting Summary & closing Remarks

Discussion, Meeting Summary & closing Remarks

Chairperson :

Bassam Atallah
Cleveland Clinic Abu Dhabi

Close

x

*The scientific program is subject to change.

O

Our Location

Jumeirah Creekside Hotel, Dubai

S

Silver Sponsors

Novartis is reimagining medicine to improve and extend people’s lives. We deliver high-value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. About 103,000 people of more than 140 nationalities work together to bring Novartis products to nearly 800 million people around the world. Find out more at https://www.novartis.com

Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. More than 52,000 employees serve over 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Learn more at www.boehringer-ingelheim.com

A

Associate Sponsors

C

Contact Us

  • Meeting Minds Experts: Office 508 & 509, DSO Tower Building, Dubai Studio City
  • +971 4 2761444
  • registration@me-cvpt.com

Address

Vifor International AG Rep Office
Aspin Commercial Building · 33rd Floor
Office No: 3301 & 3304
Sheikh Zayed Road
PO Box 414087 · Dubai · U.A.E

Stay in touch

Keep up to date on social media or contact us with any other information +41 58 851 80 00
For any Medical information enquiries please send an email to: Medinfo_GCC@viforpharma.com
For adverse event please report to: drugsafety-gcc@viforpharma.com

Copyright © 2023. All rights Reserved.